Archives
-
HyperFluor 488: From Vaccine Data to Assay
2026-09-10
Learn how the HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody converts vaccine-immunology questions into rigorous fluorescence assays. This evidence-led guide focuses on species selection, endpoint interpretation, controls, and workflow design rather than repeating a standard product description.
-
Ro 3306: CDK1 Inhibitor Workflow
2026-09-10
Ro 3306 enables controlled G2/M arrest, synchronized cancer-cell populations, and phase-resolved studies of mitotic entry, DNA repair, and mTORC1 biology. This practical guide combines product-specific handling advice with workflow enhancements and troubleshooting strategies for reproducible experiments.
-
Optimized GBA1 mRNA for Gaucher Disease Therapy
2026-09-09
The reference study systematically optimized human GBA1 mRNA through untranslated-region design, codon usage, and poly(A)-tail engineering. Its lead constructs produced sustained glucocerebrosidase expression, restored lysosomal phenotypes in GBA1-knockout cells, and generated measurable enzyme activity in mouse liver and spleen after lipid nanoparticle delivery, while important translational questions remain.
-
CREC Carbapenemase Gene Transmission in Guangdong
2026-09-09
Chen et al. integrated gene localization, conjugation testing, mobile-element analysis, and strain typing to characterize carbapenem-resistant Enterobacter cloacae from eight teaching hospitals in Guangdong. The high transferability of blaNDM-1 and its association with multidrug resistance provide a practical framework for antimicrobial resistance research and hospital surveillance.
-
Estradiol, GPR30, and ER Stress After Hemorrhagic Shock
2026-09-08
This study shows that 17β-estradiol restores splenic CD4+ T-lymphocyte function after hemorrhagic shock by reducing endoplasmic reticulum stress through ERα- and GPR30-dependent mechanisms, but not ERβ. Its integrated use of receptor-selective agonists, antagonists, an endoplasmic reticulum stress inhibitor, and an inducer provides a useful framework for mechanistic estrogen signaling research in trauma immunology.
-
Urolithin A Experimental Workflows
2026-09-08
Build reproducible mitochondrial quality-control assays with Urolithin A while connecting mitophagy, respiratory function, and metabolic remodeling. This workflow also shows how to extend mitochondrial experiments into hepatic stellate cell and skeletal muscle models without confusing established evidence with testable hypotheses.
-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-09-07
Saito and colleagues developed a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The organoids could be cryopreserved, differentiated into intestinal epithelial cells, and used to assess cytochrome P450 and transporter activities relevant to oral drug pharmacokinetics.
-
Griseofulvin Workflows for Microtubule Assays
2026-09-07
Griseofulvin provides a practical way to connect fungal mitosis phenotypes with mechanism-aware microtubule assays. This workflow combines DMSO handling, timed exposure, microscopy, and flow-cytometric readouts to distinguish general toxicity from microtubule disruption and aneugenic signatures.
-
Annexin V-PE Reagent for CAR-T Assays
2026-09-05
Learn how the Annexin V-PE Reagent converts phosphatidylserine externalization into an interpretable CAR-T cytotoxicity readout. This guide connects CD38 binder biology with assay controls, gating strategy, and orthogonal validation.
-
3-Bromopyruvate Reverses Cetuximab Resistance in CRC
2026-09-04
The reference study shows that combining 3-bromopyruvate with cetuximab suppresses colorectal cancer models that are intrinsically or adaptively resistant to cetuximab. Its central mechanistic contribution is linking restored FOXO3a activity to AMPKα/Beclin1-associated autophagy, ferroptosis, and PUMA-associated apoptosis, providing a preclinical framework for combination treatment.
-
MVC Entry, RhoA/ROCK1 Signaling, and Occludin
2026-09-04
The reference study identifies a previously unrecognized connection between MVC VP2 and ROCK1 and shows how RhoA/ROCK1/MLC2 signaling disrupts tight junction organization during infection. Its findings position Occludin as a potential MVC co-receptor and suggest that cytoskeletal barrier regulation is an actionable stage of viral entry.
-
Brain-to-Spinal Circuits in Mechanical Allodynia
2026-09-03
The reference study identifies a contralateral lPBN–hypothalamus–spinal circuit that regulates both the spread and persistence of mechanical allodynia in mice. Its findings connect Oprm1 and Pdyn neuronal populations with spinal κ-opioid receptor signaling, providing a mechanistic framework for studying bilateral pain hypersensitivity and receptor-dependent descending inhibition.
-
Astrocytic GAT-3 in Dentate Gyrus Memory
2026-09-03
The reference study identifies astrocytic GAT-3 as an active regulator of dentate gyrus synaptic transmission rather than merely a GABA clearance mechanism. By linking GAT-3-dependent astrocytic calcium signaling to presynaptic GluN2B-containing NMDARs and contextual fear memory, the work provides a mechanistic framework for studying glia-neuron control of hippocampal function.
-
Bestatin Inhibition of Leucine Aminopeptidase
2026-09-02
The reference study used high-resolution X-ray crystallography to show how Bestatin occupies the leucine aminopeptidase active site and coordinates its exchangeable zinc ion. Its binding geometry supports a transition-state-like model for peptide hydrolysis, providing a structural framework for interpreting inhibitor potency, substrate recognition, and follow-up enzyme studies.
-
ML216: BLM Helicase Inhibitor Workflows
2026-09-02
ML216 enables mechanism-focused studies of BLM-dependent DNA repair, sister chromatid exchange, and selective cell proliferation inhibition. This practical guide connects biochemical benchmarking with cellular validation, chemotherapy-sensitization experiments, and careful interpretation of related WRN-helicase literature.